We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Anna MacDonald

Anna MacDonald

Science Writer

Contact Us

After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.


Latest Content
Agilent Science Futures – An Interview With Alexandra Richardson
Industry Insight

Agilent Science Futures – An Interview With Alexandra Richardson

In this interview, Alexandra Richardson tells us more about her research, the role that technology is playing in it and how important industry partnerships have been.
Overcoming Challenges of Biologic Characterization
Industry Insight

Overcoming Challenges of Biologic Characterization

To learn more about the Biophase 8800 system and how it can help to overcome current bioanalytical challenges, Technology Networks spoke to Mani Krishnan, vice president and general manager, SCIEX CE and Biopharma.
Driving Innovation in Insect Farming
Industry Insight

Driving Innovation in Insect Farming

What benefits can insect protein offer? How are regulatory frameworks impacting innovation in this field? And what can be done to drive further advances? Technology Networks had the pleasure of speaking with Thomas Farrugia, chief executive officer of Beta Bugs Limited, to answer these questions and more.
Developing a Vaccine for Alzheimer’s Disease
Industry Insight

Developing a Vaccine for Alzheimer’s Disease

To learn more about a universal vaccine technology and how the platform could be applied to Alzheimer's disease and other neurological indications, Technology Networks spoke with Roman Kniazev, chief executive officer at Nuravax.
Gut Instinct Should Not Play a Part in Drug Repurposing
Article

Gut Instinct Should Not Play a Part in Drug Repurposing

Technology Networks spoke to Ahmad Besaratinia, PhD, professor of Research Population and Public Health Sciences, Keck School of Medicine of USC to find out more about drug repurposing and the dangers that come with using a drug without fully assessing its potential for harm.
Optimizing Your Cryopreservation
Infographic

Optimizing Your Cryopreservation

This infographic highlights steps you can take to protect your samples and improve your cryopreservation workflow.
Agilent Science Futures – The Impact of Academia–Industry Relationships on the Next Generation of Scientists
Industry Insight

Agilent Science Futures – The Impact of Academia–Industry Relationships on the Next Generation of Scientists

There is an inherent link between academia and industry that rarely gets the acknowledgement it deserves. Hear from a roundtable of PhD students on the impact that the collaborative relationship between academia and industry has on their work and the role that technology plays in the “Science Futures” initiative.
Keeping Pace With Trends and Developments in Analytical Science
Industry Insight

Keeping Pace With Trends and Developments in Analytical Science

Technology Networks spoke with Peter Zipfell to learn more about the Innovation Summits and the key themes that will be explored at the events. In this interview, Peter also shares his thoughts on current trends in analytical technologies and software.
Building the World’s First University Cloud Lab
Industry Insight

Building the World’s First University Cloud Lab

To learn more about the CMU Cloud Lab, the motivation behind the project and the benefits it will bring, Technology Networks spoke to Rebecca Doerge, PhD, dean, Mellon College of Science, Carnegie Mellon University, and Toby Blackburn, head of business development and research, Emerald Cloud Lab.
Simplifying Complex Wound Care With Innovative Medical Technologies
Industry Insight

Simplifying Complex Wound Care With Innovative Medical Technologies

Technology Networks recently spoke with Richard Hague, PolarityTE’s chief executive officer and president, to learn more about the science behind SkinTE and how it could overcome some of the limitations associated with other chronic wound treatments.
Advertisement